Metastatic Melanoma Progression Is Associated with Endothelial Nitric Oxide Synthase Uncoupling Induced by Loss of

Fabiana Henriques Machado de Melo1,2, Diego Assis Gonçalves3,4, Ricardo Xisto de Sousa5

  • 1Pharmacology Department, Universidade Federal de São Paulo, São Paulo 05508-090, Brazil.

Insights

Endothelial nitric oxide synthase (eNOS) dysfunction contributes to aggressive melanoma by increasing reactive oxygen species. Restoring eNOS activity reduced tumor growth and chemoresistance, highlighting eNOS as a potential therapeutic target.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Melanoma's aggressiveness stems from metastasis and chemoresistance, often linked to altered redox homeostasis and increased reactive oxygen species (ROS).
  • Endothelial nitric oxide synthase (eNOS) dysfunction, producing superoxide anion (O2-•), establishes a pro-oxidant environment crucial for melanoma progression.
  • While reduced tetrahydrobiopterin (BH4) is typically linked to eNOS uncoupling, metastatic melanoma cells exhibit high BH4 levels despite eNOS uncoupling.

Purpose of the Study:

  • To investigate the role of eNOS dysfunction in metastatic melanoma.
  • To explore the relationship between BH4 concentration, eNOS expression, and eNOS uncoupling in melanoma.
  • To evaluate the therapeutic potential of restoring eNOS activity in melanoma treatment.

Main Methods:

  • Western blot analysis to assess eNOS and BH4 levels.
  • Gene expression analysis of biopterin synthesis pathway genes (Gch1, Pts, Spr).
  • In vitro treatments with L-sepiapterin and eNOS downregulation; in vivo tumor growth studies.

Main Results:

  • Metastatic melanoma cells showed increased NOS3 expression and high BH4 levels, leading to eNOS uncoupling and increased O2-•.
  • L-sepiapterin treatment and eNOS downregulation restored NOS coupling, increased nitric oxide (NO), decreased O2, and reduced cell growth, anoikis resistance, and dacarbazine chemoresistance.
  • Restoration of eNOS activity inhibited tumor growth in vivo, and NOS3 expression was elevated in human metastatic melanoma samples.

Conclusions:

  • eNOS uncoupling, despite high BH4, is a key mechanism in metastatic melanoma, driven by increased NOS3 expression.
  • Targeting eNOS activity by restoring its function presents a promising therapeutic strategy for melanoma, impacting tumor growth and chemoresistance.
  • eNOS dysfunction represents a significant contributor to melanoma metastasis and warrants further investigation as a therapeutic target.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.1K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K